SLC7A11 functions in proliferation and invasion, but Yang et al found that overexpression of the antisense transcript of SLC7A11 (SLC7A11‐AS1) in pancreatic cancer cells promotes gemcitabine resistance by reducing ROS levels through the inhibition of the ubiquitination and degradation of nuclear factor erythroid‐2‐related factor 2 (NRF2).98 The gene discussed is SLC7A11; the disease is pancreatic neoplasm.